Jaafar Bennouna - Researcher Profile

Publications

3 shown

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Luis Paz‐Ares , Tudor‐Eliade Ciuleanu , Manuel Cobo +24 more

2021 The Lancet Oncology 1273 citations

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

Takashi Kojima , Manish A. Shah , Kei Muro +24 more

PURPOSE Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy. PATIENTS AND METHODS In this open-label, phas...

2020 Journal of Clinical Oncology 1110 citations

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy , Françoise Desseigne , Marc Ychou +17 more

International audience

2011 New England Journal of Medicine 7440 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 9,823
Institution: Inserm

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-5034-1108

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.